Image: StatnewsIn win for RFK Jr., FDA advisory panel narrowly votes to allow compounding of unapproved peptides
• An FDA advisory panel narrowly voted to recommend allowing compounding pharmacies to produce BPC-157 and KPV, two popular but unproven peptides. • The decision follows advocacy from Robert F. Kennedy Jr., who pushed for increased access to these substances despite their lack of formal FDA approval. • This move is significant as it challenges standard regulatory hurdles for unapproved drugs, potentially expanding patient access to experimental treatments.
statnews.com


